SCHEMBL10167462

SCHEMBL10167462

CCCC(=O)N(CC)c1nsc2cccc(Cl)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 3/20 0.33
LMNA P02545 2/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MCL1 Q07820 1/20 0.33
OGG1 O15527 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
ALOX5 P09917 1/20 0.32
GAA P10253 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10167456 0.90 ALDH1A1 (0.39) TP53KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL10167449 0.86 ALDH1A1 (0.38) TP53KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL10167434 0.86 ALDH1A1 (0.37) TP53KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL10167516 0.83 KCNA5 (0.41) TP53KDM4EALDH1A1MAPTMEN1
SCHEMBL10167466 0.82 HTT (0.38) TP53KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL10167469 0.81 ALDH1A1 (0.34) TP53KDM4EALDH1A1MAPK1L3MBTL1
SCHEMBL10167459 0.81 TP53 (0.42) TP53KDM4EALDH1A1MAPTLMNA
SCHEMBL10167672 0.79 HCRTR1 (0.35) TP53KDM4EMAPK1MAPTLMNA
SCHEMBL10167447 0.78 ALDH1A1 (0.40) KDM4EALDH1A1MAPK1L3MBTL1MAPT
SCHEMBL358113 0.77 KMT2A (0.40) TP53ALDH1A1L3MBTL1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
WO-2008090048-A2 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BPNT1, BCAT1, TGFBR1 TP53 4256/4885KDM4E 3057/4885ALDH1A1 452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.